Farnesyl pyrophosphate is a new danger signal inducing acute cell death

Chen, Jing and Zhang, Xiaochen and Li, Liping and Ma, Xianqiang and Yang, Chunxiao and Liu, Zhaodi and Li, Chenyang and Fernandez-Cabezudo, Maria J. and al-Ramadi, Basel K. and Wu, Chuan and Huang, Weishan and Zhang, Yong and Zhang, Yonghui and Liu, Wanli and Daneman, Richard (2021) Farnesyl pyrophosphate is a new danger signal inducing acute cell death. PLOS Biology, 19 (4). e3001134. ISSN 1545-7885

[thumbnail of journal.pbio.3001134.pdf] Text
journal.pbio.3001134.pdf - Published Version

Download (3MB)

Abstract

Cell death is a vital event in life. Infections and injuries cause lytic cell death, which gives rise to danger signals that can further induce cell death, inflammation, and tissue damage. The mevalonate (MVA) pathway is an essential, highly conserved and dynamic metabolic pathway. Here, we discover that farnesyl pyrophosphate (FPP), a metabolic intermediate of the MVA pathway, functions as a newly identified danger signal to trigger acute cell death leading to neuron loss in stroke. Harboring both a hydrophobic 15-carbon isoprenyl chain and a heavily charged pyrophosphate head, FPP leads to acute cell death independent of its downstream metabolic pathways. Mechanistically, extracellular calcium influx and the cation channel transient receptor potential melastatin 2 (TRPM2) exhibit essential roles in FPP-induced cell death. FPP activates TRPM2 opening for ion influx. Furthermore, in terms of a mouse model constructing by middle cerebral artery occlusion (MCAO), FPP accumulates in the brain, which indicates the function of the FPP and TRPM2 danger signal axis in ischemic injury. Overall, our data have revealed a novel function of the MVA pathway intermediate metabolite FPP as a danger signal via transient receptor potential cation channels.

Item Type: Article
Subjects: Journal Eprints > Biological Science
Depositing User: Managing Editor
Date Deposited: 30 Jan 2023 08:56
Last Modified: 24 May 2024 05:32
URI: http://repository.journal4submission.com/id/eprint/803

Actions (login required)

View Item
View Item